SULPROSTONE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C23H31NO7S
Molecular Weight	465.56
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure of SULPROSTONE

Structure Search

SMILES

CS(=O)(=O)NC(=O)CCC\C=C/C[C@@H]1[C@@H](\C=C\[C@@H](O)COC2=CC=CC=C2)[C@H](O)CC1=O

InChI

InChIKey=UQZVCDCIMBLVNR-TWYODKAFSA-N

InChI=1S/C23H31NO7S/c1-32(29,30)24-23(28)12-8-3-2-7-11-19-20(22(27)15-21(19)26)14-13-17(25)16-31-18-9-5-4-6-10-18/h2,4-7,9-10,13-14,17,19-20,22,25,27H,3,8,11-12,15-16H2,1H3,(H,24,28)/b7-2-,14-13+/t17-,19-,20-,22-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C23H31NO7S
Molecular Weight	465.56
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	4 / 4
E/Z Centers	2
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:23:23 UTC 2023` Edited by `admin` on `Sat Dec 16 16:23:23 UTC 2023`
Record UNII	501Q5EQ1GM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SULPROSTONE

Official Name

English

sulprostone [INN]

Common Name

English

CP-34089

Code

English

CP-34,089

Code

English

SULPROSTONE [USAN]

Common Name

English

SULPROSTONE [MART.]

Common Name

English

5-HEPTENAMIDE, 7-(3-HYDROXY-2-(3-HYDROXY-4-PHENOXY-1-BUTENYL)-5-OXOCYCLOPENTYL)-N-(METHYLSULFONYL)-, (1R-(1A(Z),2B(1E,3R*),3A))-

Systematic Name

English

ZK-57+G1872671

Code

English

ZK 57 671

Code

English

SULPROSTONE [MI]

Common Name

English

Sulprostone [WHO-DD]

Common Name

English

(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E)-(3R)-(3-hydroxy-4-phenoxy-1-butenyl)]-5-oxocyclopentyl]-N-(methylsulfonyl)-5-heptenamide

Systematic Name

English

ZK-57671

Code

English

Classification Tree Code System Code

WHO-VATC

QG02AD05

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

NCI_THESAURUS

C78568

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

WHO-ATC

G02AD05

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

Code System Code Type Description

WIKIPEDIA

Sulprostone

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

CAS

60325-46-4

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

NCI_THESAURUS

C84191

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

ChEMBL

CHEMBL1472830

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

MERCK INDEX

m10390

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

Merck Index

EPA CompTox

DTXSID5049029

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

PUBCHEM

5312153

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

EVMPD

SUB10760MIG

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

DRUG BANK

DB12708

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

INN

4243

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

MESH

C016767

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

DRUG CENTRAL

2538

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

FDA UNII

501Q5EQ1GM

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

SMS_ID

100000092603

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

ECHA (EC/EINECS)

262-173-0

Created by admin on Sat Dec 16 16:23:24 UTC 2023 , Edited by admin on Sat Dec 16 16:23:24 UTC 2023

PRIMARY

Related Record Type Details


					D381C4K8ZW

PROSTAGLANDIN E2 RECEPTOR EP1 SUBTYPE

TARGET -> AGONIST

Qualification:

Ki

Amount:


					7L8YW0VG16

PROSTAGLANDIN E2 RECEPTOR EP3 SUBTYPE

TARGET -> AGONIST

Qualification:

Ki

Amount:


					6GS8S5F0RP

PROSTAGLANDIN E2 RECEPTOR EP2 SUBTYPE

OFF TARGET->NON-INHIBITOR

Qualification:

Ki

Amount:


					5NTX6739W3

PROSTAGLANDIN F2-ALPHA RECEPTOR

TARGET -> AGONIST

Qualification:

Ki

Amount:


					6EM0N6I9ZP

PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE

TARGET->WEAK AGONIST

Qualification:

Ki

Amount:


					7L8YW0VG16

PROSTAGLANDIN E2 RECEPTOR EP3 SUBTYPE

TARGET -> AGONIST

Comments:

Inhibition of 3H-NE release

Qualification:

EC50

Amount:

Related Record Type Details


					501Q5EQ1GM

ACTIVE MOIETY

Amount: